Obesity
Showing NaN - NaN of 99
Obesity, Type 2 Diabetes Trial in Birmingham (Dietary)
Completed
- Obesity
- Type 2 Diabetes
- Dietary
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Nov 21, 2019
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
Obesity Trial in Birmingham (Intranasal Insulin, Intranasal Placebo)
Completed
- Obesity
- Intranasal Insulin
- Intranasal Placebo
-
Birmingham, United KingdomUniverisity of Birmingham
Apr 30, 2019
Glucose Intolerance, Obesity Trial in Birmingham (Low glycemic load snacks)
Completed
- Glucose Intolerance
- Obesity
- Low glycemic load snacks
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Mar 21, 2019
Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States
Unknown status
- Endometrial Clear Cell Adenocarcinoma
- +6 more
- 3-Dimensional Conformal Radiation Therapy
- +7 more
-
Birmingham, Alabama
- +539 more
Mar 8, 2019
Obesity Trial in Birmingham (Mindful Construal Diary)
Completed
- Obesity
- Mindful Construal Diary
-
Birmingham, West Midlands, United KingdomHeartlands Hospital
Jan 31, 2019
Obesity, Breast Cancer Trial in Birmingham (Walking+simulated-altitude, Walking (control))
Completed
- Obesity
- Breast Cancer
- Walking+simulated-altitude
- Walking (control)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
May 7, 2018
Obesity Trial in United States (S-2367 Placebo, S-2367 1600 mg q.d. 54 Weeks, S-2367 1600 mg q.d. 60 weeks)
Completed
- Obesity
- S-2367 Placebo
- +4 more
-
Birmingham, Alabama
- +39 more
May 9, 2018
Obesity Trial in United States (S-2367 (velneperit))
Completed
- Obesity
- S-2367 (velneperit)
-
Birmingham, Alabama
- +72 more
Apr 26, 2018
HERO Study: Helping Evaluate Reduction in Obesity
Completed
- Obesity
- LAP-BAND APĀ® Adjustable Gastric Banding System
-
Everett, Washington
- +5 more
Feb 8, 2018
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Birmingham, Alabama
- +225 more
Dec 20, 2017
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Vestavia Hills, Alabama
- +160 more
Dec 6, 2017
Obesity Trial in Birmingham (Diet, Aerobic exercise, Resistance exercise)
Completed
- Obesity
- Diet
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Nov 16, 2017
Obesity, Diabetes, Hypertension Trial in Birmingham (Exercise, Reduced Calorie Diet, Weight Maintenance Diet)
Completed
- Obesity
- +3 more
- Exercise
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 1, 2017
Obesity Trial in Birmingham (Egg-based diet (EBD), Carbohydrate-based diet (CBD))
Completed
- Obesity
- Egg-based diet (EBD)
- Carbohydrate-based diet (CBD)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 16, 2017
Vitamin D Deficiency in Obese Adolescent Girls and Influence of
Completed
- Vitamin D Deficiency
- +2 more
-
Birmingham, AlabamaChildren's Hospital, Universiy of Alabama at Birmingham
Apr 7, 2017
Obesity, Cardiovascular Diseases Trial in United States (Naltrexone HCl/Bupropion HCl ER, Placebo)
Terminated
- Obesity
- Cardiovascular Diseases
- Naltrexone HCl/Bupropion HCl ER
- Placebo
-
Alexander City, Alabama
- +138 more
Feb 21, 2017
Type 2 Diabetes, Obesity Trial in United States (EndoBarrier, Sham Procedure)
Terminated
- Type 2 Diabetes
- Obesity
- EndoBarrier
- Sham Procedure
-
Birmingham, Alabama
- +24 more
Dec 2, 2016
Type 2 Diabetes, Obesity, Diabesity Trial in Birmingham, Glasgow, London (Liraglutide, Duodenal-jejunal bypass liner -
Unknown status
- Type 2 Diabetes
- +2 more
- Liraglutide
- Duodenal-jejunal bypass liner - Endobarrier device
-
Birmingham, United Kingdom
- +3 more
Apr 25, 2016
Obesity Trial in Birmingham (thermostat)
Completed
- Obesity
- thermostat
-
Birmingham, AlabamaUniversity of Alabama at Birmingham School of Public Health
Nov 9, 2015
Breast Cancer, Overweight, Obesity Trial in United States (Less Intensive, Intensive Group)
Completed
- Breast Cancer
- +2 more
- Less Intensive
- Intensive Group
-
Birmingham, Alabama
- +3 more
Jun 17, 2015
Obesity Trial in United States (Placebo, Pramlintide and Metreleptin)
Completed
- Obesity
- Placebo
- Pramlintide and Metreleptin
-
Birmingham, Alabama
- +32 more
Mar 26, 2015